{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T10:13:22Z","timestamp":1756894402763,"version":"3.37.3"},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T00:00:00Z","timestamp":1589846400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0232619","type":"journal-article","created":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T21:13:41Z","timestamp":1589922821000},"page":"e0232619","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effect of hepato-toxins in the acceleration of hepatic fibrosis in hepatitis B mice"],"prefix":"10.1371","volume":"15","author":[{"given":"Suchithra","family":"Poilil Surendran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reju","family":"George Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myeong Ju","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rayoung","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doo Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyun Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6096-3130","authenticated-orcid":true,"given":"Yong Yeon","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,5,19]]},"reference":[{"issue":"2","key":"pone.0232619.ref001","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"R Bataller","year":"2005","journal-title":"J Clin Invest"},{"issue":"1","key":"pone.0232619.ref002","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4103\/1319-3767.45072","article-title":"Reversal of liver fibrosis","volume":"15","author":"M Ismail","year":"2009","journal-title":"Saudi J Gastroenterol"},{"issue":"SUPPL.1","key":"pone.0232619.ref003","first-page":"2","article-title":"Origin of myofibroblasts in liver fibrosis","volume":"5","author":"DA Brenner","year":"2012","journal-title":"Fibrogenes Tissue Repair"},{"issue":"1","key":"pone.0232619.ref004","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/hep.21459","article-title":"Hepatic fibrosis 2006: Report of the third AASLD single topic conference","volume":"45","author":"SL Friedman","year":"2007","journal-title":"Hepatology"},{"issue":"1","key":"pone.0232619.ref005","first-page":"283","volume":"331","author":"TG Bird","year":"2011","journal-title":"Europe PMC Funders Group Activation of stem cells in hepatic diseases"},{"issue":"2","key":"pone.0232619.ref006","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bpg.2011.02.005","article-title":"Mechanisms of hepatic fibrogenesis","volume":"25","author":"UE Lee","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"3","key":"pone.0232619.ref007","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.tox.2008.06.013","article-title":"Hepatic fibrosis-Overview","volume":"254","author":"SL Friedman","year":"2008","journal-title":"Toxicology"},{"issue":"4","key":"pone.0232619.ref008","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1478-3231.2007.01469.x","article-title":"Liver fibrosis: Searching for cell model answers","volume":"27","author":"MC Guti\u00e9rrez-Ruiz","year":"2007","journal-title":"Liver Int"},{"issue":"6","key":"pone.0232619.ref009","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.arcmed.2006.10.001","article-title":"Liver Fibrosis and Chronic Viral Hepatitis","volume":"38","author":"G Gutierrez-Reyes","year":"2007","journal-title":"Arch Med Res"},{"issue":"3","key":"pone.0232619.ref010","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/hep.21347","article-title":"Global challenges in liver disease","volume":"44","author":"R Williams","year":"2006","journal-title":"Hepatology"},{"issue":"1","key":"pone.0232619.ref011","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.canlet.2008.10.040","article-title":"Liver cancer: Descriptive epidemiology and risk factors other than HBV and HCV infection","volume":"286","author":"SC Chuang","year":"2009","journal-title":"Cancer Lett"},{"issue":"4","key":"pone.0232619.ref012","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2006.05.013","article-title":"The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide","volume":"45","author":"JF Perz","year":"2006","journal-title":"J Hepatol"},{"issue":"APR","key":"pone.0232619.ref013","article-title":"Hepatitis B virus immunopathology, model systems, and current therapies","volume":"8","author":"P Sandhu","year":"2017","journal-title":"Front Immunol"},{"issue":"1","key":"pone.0232619.ref014","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3748\/wjg.v13.i1.82","article-title":"Pathogenesis of hepatitis B virus infection","volume":"13","author":"TF Baumert","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"1","key":"pone.0232619.ref015","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1128\/CMR.00018-11","article-title":"Molecular mechanisms underlying occult hepatitis B virus infection","volume":"25","author":"J Samal","year":"2012","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"pone.0232619.ref016","doi-asserted-by":"crossref","first-page":"85","DOI":"10.5625\/lar.2018.34.3.85","article-title":"Mouse models for hepatitis B virus research","volume":"34","author":"J-R Hwang","year":"2018","journal-title":"Lab Anim Res"},{"issue":"2017","key":"pone.0232619.ref017","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ijid.2017.04.002","article-title":"Humanized chimeric mouse models of hepatitis B virus infection","volume":"59","author":"S Sun","year":"2017","journal-title":"Int J Infect Dis"},{"issue":"3","key":"pone.0232619.ref018","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2006.03.017","article-title":"Combination of systemic thioacetamide (TAA) injections and ethanol feeding accelerates hepatic fibrosis in C3H\/He mice and is associated with intrahepatic up regulation of MMP-2, VEGF and ICAM-1","volume":"45","author":"M Kornek","year":"2006","journal-title":"J Hepatol"},{"issue":"5","key":"pone.0232619.ref019","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1053\/jhep.2002.36780","article-title":"Risk factors for hepatocellular carcinoma: Synergism of alcohol with viral hepatitis and diabetes mellitus","volume":"36","author":"MM Hassan","year":"2002","journal-title":"Hepatology"},{"issue":"1","key":"pone.0232619.ref020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.14218\/JCTH.2014.00035","article-title":"Animal Models for Fibrotic Liver Diseases: What We Have, What We Need, and What Is under Development","volume":"3","author":"P Sta","year":"2015","journal-title":"J Clin Transl Hepatol"},{"issue":"2","key":"pone.0232619.ref021","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/hep.26379","article-title":"Hepatitis B virus inhibits liver regeneration via epigenetic regulation of urokinase-type plasminogen activator","volume":"58","author":"ES Park","year":"2013","journal-title":"Hepatology"},{"issue":"1","key":"pone.0232619.ref022","article-title":"Intracellular interleukin-32\u03b3 mediates antiviral activity of cytokines against hepatitis B virus","volume":"9","author":"DH Kim","year":"2018","journal-title":"Nat Commun"},{"issue":"12","key":"pone.0232619.ref023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0145512","article-title":"Effectiveness of losartan-loaded hyaluronic acid (HA) micelles for the reduction of advanced hepatic fibrosis in C3H\/HeN mice model","volume":"10","author":"RG Thomas","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"pone.0232619.ref024","first-page":"1","article-title":"The dose of HBV genome contained plasmid has a great impact on HBV persistence in hydrodynamic injection mouse model","volume":"14","author":"L Li","year":"2017","journal-title":"Virol J"},{"issue":"1","key":"pone.0232619.ref025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13069-016-0042-4","article-title":"Age-dependent development of liver fibrosis in Glmpgt\/gt mice","volume":"9","author":"CK Nesset","year":"2016","journal-title":"Fibrogenes Tissue Repair"},{"issue":"76","key":"pone.0232619.ref026","doi-asserted-by":"crossref","first-page":"34213","DOI":"10.18632\/oncotarget.25789","article-title":"Clearance of HBeAg and HBsAg of HBV in mice model by a recombinant HBV vaccine combined with GM-CSF and IFN-\u03b1 as an effective therapeutic vaccine adjuvant","volume":"9","author":"W Zhao","year":"2018","journal-title":"Oncotarget"},{"issue":"1","key":"pone.0232619.ref027","article-title":"Ciclopirox inhibits Hepatitis B Virus secretion by blocking capsid assembly","volume":"10","author":"JA Kang","year":"2019","journal-title":"Nat Commun"},{"key":"pone.0232619.ref028","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/431750","article-title":"Comparison of Histochemical Stainings in Evaluation of Liver Fibrosis and Correlation with Transient Elastography in Chronic Hepatitis","volume":"2015","author":"D Cabibi","year":"2015","journal-title":"Anal Cell Pathol"},{"issue":"8","key":"pone.0232619.ref029","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/j.1365-2036.2006.03110.x","article-title":"Review article: Alcoholic liver disease\u2014Pathophysiological aspects and risk factors","volume":"24","author":"A Gramenzi","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"pone.0232619.ref030","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.3390\/biom5042978","article-title":"Update on alcoholic hepatitis","volume":"5","author":"NJ Torok","year":"2015","journal-title":"Biomolecules"},{"issue":"4","key":"pone.0232619.ref031","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/cmi.2011.53","article-title":"Liver fibrosis: Mechanisms of immune-mediated liver injury","volume":"9","author":"R Xu","year":"2012","journal-title":"Cell Mol Immunol"},{"key":"pone.0232619.ref032","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jviromet.2014.03.015","article-title":"Construction of replication competent plasmids of hepatitis B virus subgenotypes A1, A2 and D3 with authentic endogenous promoters","volume":"203","author":"NH Bhoola","year":"2014","journal-title":"J Virol Methods"},{"issue":"2","key":"pone.0232619.ref033","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/mt.2013.212","article-title":"An efficient antiviral strategy for targeting hepatitis B virus genome using transcription activator-like effector nucleases","volume":"22","author":"J Chen","year":"2014","journal-title":"Mol Ther"},{"issue":"23","key":"pone.0232619.ref034","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.3748\/wjg.14.3733","article-title":"Construction and expression of eukaryotic plasmids containing lamivudine-resistant or wild-type strains of Hepatitis B virus genotype C","volume":"14","author":"WZ Xu","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"4","key":"pone.0232619.ref035","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/hep.22109","article-title":"Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease","volume":"47","author":"WR Kim","year":"2008","journal-title":"Hepatology"},{"issue":"1","key":"pone.0232619.ref036","doi-asserted-by":"crossref","first-page":"FSO250","DOI":"10.4155\/fsoa-2017-0083","article-title":"Liver fibrosis: a compilation on the biomarkers status and their significance during disease progression","volume":"4","author":"KS Nallagangula","year":"2018","journal-title":"Futur Sci OA"},{"issue":"5","key":"pone.0232619.ref037","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S1525-0016(03)00244-2","article-title":"Small interfering RNA inhibits hepatitis B virus replication in mice","volume":"8","author":"H Giladi","year":"2003","journal-title":"Mol Ther"},{"issue":"6","key":"pone.0232619.ref038","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/hep.23571","article-title":"Serum hepatitis B surface antigen and hepatitis B e antigen titers: Disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers","volume":"51","author":"AJV Thompson","year":"2010","journal-title":"Hepatology"},{"issue":"47","key":"pone.0232619.ref039","first-page":"1","volume":"103","author":"L-R Huang","year":"2006","journal-title":"Sciences of the USA 17862\u201317867 PNAS"},{"issue":"17","key":"pone.0232619.ref040","doi-asserted-by":"crossref","first-page":"9266","DOI":"10.1128\/JVI.00608-12","article-title":"Hepatitis B Virus Nucleocapsid but Not Free Core Antigen Controls Viral Clearance in Mice","volume":"86","author":"Y-J Lin","year":"2012","journal-title":"J Virol"},{"issue":"20","key":"pone.0232619.ref041","doi-asserted-by":"crossref","first-page":"9340","DOI":"10.1073\/pnas.1004762107","article-title":"Hepatitis B virus core antigen determines viral persistence in a C57BL\/6 mouse model","volume":"107","author":"Y-J Lin","year":"2010","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"pone.0232619.ref042","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.dld.2004.11.009","article-title":"Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation","volume":"37","author":"G Carpino","year":"2005","journal-title":"Dig Liver Dis"},{"issue":"3","key":"pone.0232619.ref043","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1365-2559.2005.02226.x","article-title":"The value of??-SMA in the evaluation of hepatic fibrosis severity in hepatitis B infection and cirrhosis development: A histopathological and immunohistochemical study","volume":"47","author":"N Akpolat","year":"2005","journal-title":"Histopathology"},{"journal-title":"Hepatic Stellate Cells and Liver Cancer","year":"2007","author":"RF SCHWABE","key":"pone.0232619.ref044"},{"issue":"S1","key":"pone.0232619.ref045","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1002\/cld.148","article-title":"Role of special stains in diagnostic liver pathology","volume":"2","author":"M Krishna","year":"2013","journal-title":"Clin Liver Dis"},{"issue":"4","key":"pone.0232619.ref046","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3350\/cmh.2017.0078","article-title":"Histopathological evaluation of liver fibrosis and cirrhosis regression","volume":"23","author":"RC Lo","year":"2017","journal-title":"Clin Mol Hepatol"},{"issue":"3","key":"pone.0232619.ref047","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/abbs\/gmq129","article-title":"Texture analysis of liver fibrosis microscopic images: A study on the effect of biomarkers","volume":"43","author":"A Amin","year":"2011","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"pone.0232619.ref048","doi-asserted-by":"crossref","unstructured":"WaAng R, Wu B. Salvianolic acid A attenuates CCl 4 -induced liver fi brosis by regulating the PI3K \/ AKT \/ mTOR, Bcl-2 \/ Bax and caspase-3 \/ cleaved caspase-3 signaling pathways. 2019;","DOI":"10.2147\/DDDT.S194787"},{"issue":"June","key":"pone.0232619.ref049","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.omtn.2019.05.001","article-title":"miR-455-3p alleviates hepatic stellate cell activation and liver fibrosis by suppressing HSF1 expression","volume":"16","author":"S Wei","year":"2019","journal-title":"Mol Ther\u2014Nucleic Acids"},{"issue":"1","key":"pone.0232619.ref050","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1242\/bio.019828","article-title":"Knockdown of histidine-rich calcium-binding protein (HRC) suppresses liver fibrosis by inhibiting the activation of hepatic stellate cells","volume":"6","author":"J Liu","year":"2017","journal-title":"Biol Open"},{"issue":"3","key":"pone.0232619.ref051","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1089\/jmf.2013.0179","article-title":"Silymarin Inhibits the Progression of Fibrosis in the Early Stages of Liver Injury in CCl 4 -Treated Rats","volume":"18","author":"S Clichici","year":"2014","journal-title":"J Med Food"},{"issue":"10","key":"pone.0232619.ref052","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075361","article-title":"Regression of Fibrosis and Reversal of Cirrhosis in Rats by Galectin Inhibitors in Thioacetamide-Induced Liver Disease","volume":"8","author":"PG Traber","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"pone.0232619.ref053","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.sjbs.2016.10.007","article-title":"Antifibrotic effects of crocin on thioacetamide-induced liver fibrosis in mice","volume":"25","author":"MM Algandaby","year":"2018","journal-title":"Saudi J Biol Sci"},{"issue":"1","key":"pone.0232619.ref054","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1080\/13880209.2018.1529801","article-title":"Anti-hepatofibrosis effect of allium senescens in activated hepatic stellate cells and thioacetamide-induced fibrosis rat model","volume":"56","author":"GM Shin","year":"2018","journal-title":"Pharm Biol"},{"issue":"7","key":"pone.0232619.ref055","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1080\/09168451.2017.1308242","article-title":"MicroRNA signatures associated with thioacetamide-induced liver fibrosis in mice","volume":"81","author":"JS Hong","year":"2017","journal-title":"Biosci Biotechnol Biochem"},{"issue":"1","key":"pone.0232619.ref056","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-28486-8","article-title":"Multiple liver insults synergize to accelerate experimental hepatocellular carcinoma","volume":"8","author":"JM Henderson","year":"2018","journal-title":"Sci Rep"},{"key":"pone.0232619.ref057","volume":"2019","author":"J Kong","year":"2019","journal-title":"Protective Effects of Nutria Bile against Thioacetamide-Induced Liver Injury in Mice"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0232619","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T21:16:02Z","timestamp":1589922962000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0232619"}},"subtitle":[],"editor":[{"given":"Wenyu","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,5,19]]},"references-count":57,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,5,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0232619","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2020,5,19]]}}}